Peter Rossing

179PUBLICATIONS
603CO-AUTHORS
Socio-economic developmentCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsMolecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (179)

|Jul 10, 2026
Prevalence, incidence, mortality, and years of life lost to diabetes from 1996 to 2024 in Denmark.

|Jul 08, 2026
Efficacy and safety of dapagliflozin in patients receiving dialysis: a post-hoc analysis of the DAPA-CKD trial.

|Jul 03, 2026
Effect of Semaglutide on Measured vs Estimated Glomerular Filtration Rate.

|Jun 18, 2026
GLP-1 receptor agonists in patients with Type 2 diabetes: cardiorenal protection versus ocular safety.

|Jun 15, 2026
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.

|Jun 08, 2026
Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.

Pageof 30

Frequent Collaborators

41 joint publications

Richard Pratley

19 joint publications

Rajiv Agarwal

19 joint publications

Katherine Tuttle

15 joint publications

Viktor Rotbain Curovic